Company appoints leading sales, market access and operations executives with decades of experience successfully launching and commercializing new oncology products
New Drug Application (NDA) for avasopasem is currently under priority review by the U.S. Food and Drug Administration (FDA) with a…
Source: www.marketscreener.com – Read more
Congress Asks How to Prevent Another Change Healthcare Crisis
The recent ransomware attack on Change Healthcare, which caused widespread disruption and financial strain for patients and healthcare professionals in the US, has prompted Congress
